title: Molecular simulations of the pairwise interaction of monoclonal antibodies.
abstract: Molecular simulations are employed to compute the free energy of pairwise monoclonal antibodies (mAbs) association using a conformational sampling algorithm with a scoring function. The work reported here is aimed at investigating the mAb-mAb association driven by weak interactions with a computational method capable of predicting experimental observations of low binding affinity. The simulations are able to explore the free energy landscape. A steric interaction component, electrostatic interactions, and a nonpolar component of the free energy form the energy scoring function. Electrostatic interactions are calculated by solving the Poisson-Boltzmann equation. The nonpolar component is derived from the van der Waals interactions upon close contact of the protein surfaces. Two mAbs with similar IgG1 framework but with small sequence differences, mAb1 and mAb2, are considered for their different viscosity and propensity to form a weak interacting dimer. mAb1 presents favorable free energy of association at pH 6 with 15 mM of ion concentration reproducing experimental trends of high viscosity and dimer formation at high concentration. Free energy landscape and minimum free energy configurations of the dimer, as well as the second virial coefficient (B22) values are calculated. The energy distributions for mAb1 are obtained, and the most probable configurations are seen to be consistent with experimental measurements. In contrast, mAb2 shows an unfavorable average free energy at the same buffer conditions due to poor electrostatic complementarity, and reversible dimer configurations with favorable free energy are found to be unlikely. Finally, the simulations of the mAb association dynamics provide insights on the self-association responsible for bulk solution behavior and aggregation, which are important to the processing and the quality of biopharmaceuticals.
authors.affiliation: Department of Late Stage Pharmaceutical Development and ‡Department of Early Stage Pharmaceutical Development, Genentech Inc., member of Roche , South San Francisco, California 94080, United States.
authors.forename: Mauro
authors.initials: M
authors.lastname: Lapelosa
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Patapoff
authors.forename: Isidro E
authors.initials: IE
authors.lastname: Zarraga
mesh_terms: D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D056004:Molecular Dynamics Simulation; D025341:Principal Component Analysis; D054730:Protein Interaction Domains and Motifs; D017434:Protein Structure, Tertiary; D055672:Static Electricity; D013816:Thermodynamics; D014783:Viscosity
chemical_list: D000911:Antibodies, Monoclonal